RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of SZLS.TO
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

FAQ

What is the symbol for StageZero Life Sciences Ltd Stock and on which exchange is it traded?
The symbol for StageZero Life Sciences Ltd is SZLS.TO and it is traded on the TSX (Toronto Stock Exchange).

Should I buy or sell StageZero Life Sciences Ltd Stock?
StageZero Life Sciences Ltd holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy StageZero Life Sciences Ltd Stock?
StageZero Life Sciences Ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy StageZero Life Sciences Ltd Stock.

What's the current price of StageZero Life Sciences Ltd Stock?
As of the end of day on the May 24, 2024, the price of an StageZero Life Sciences Ltd (SZLS.TO) share was $0.0400.

What is the 52-week high and low for StageZero Life Sciences Ltd Stock?
The 52-week high for StageZero Life Sciences Ltd Stock is $0.0750 and the 52-week low is $0.0350.

What is the market capitalization of StageZero Life Sciences Ltd Stock?
As of the May 24, 2024, the market capitalization of StageZero Life Sciences Ltd is 4.918M.

When is the next earnings date for StageZero Life Sciences Ltd?
The upcoming earnings date for StageZero Life Sciences Ltd is Aug 13, 2024.
Click to get the best stock tips daily for free!

About StageZero Life Sciences Ltd

StageZero Life Sciences Ltd StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in the United States and Canada. Its proprietary platform technology is Sentinel Principle, which identifies novel biomarkers from whole blood. The company's lead product is Aristotle, a ... SZLS.TO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT